Bloomberg Talks

Moderna CEO Stephane Bancel Talks Fourth Quarter Results

Feb 22, 2024
Guest
Stephane Bancel
Moderna CEO discusses market share growth, mRNA vaccines, and plans for new RSV vaccine in 2023. Also explores advancements in RSV, flu, and cancer vaccines, potential of single-shot COVID, flu, and RSV combo vaccine, and competition concerns.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
Exploring Moderna's Beyond COVID Vaccines and Regulatory Considerations
01:39 • 2min
3
Future Prospects of a Single-shot COVID, Flu, and RSV Combo Vaccine
04:08 • 2min